Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Editas Medicine Stock Sank Today

TheMotleyFool

0 0

Shares of Editas Medicine (NASDAQ: EDIT) were down 6.8% as of 3:51 p.m. EST on Thursday. The company didn't report any news that would cause its stock to fall. Instead, Editas' decline resulted from the overall stock market sell-off.

Clinical-stage biotech stocks tend to be a lot more volatile than the major benchmark indexes. When the market drops, these stocks often fall even harder.

What should investors do? Sit tight. Market swings come and they go. The important thing to focus on is Editas' prospects for its gene-editing therapies in development.

Source Fool.com

Like: 0

EDIT

Teilen